Texan Capital Management’s Eli Lilly LLY Stock Holding History

Texan Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-30,437	Closed	-$2.56M	–	113
2017 Q1	$2.56M	Hold	30,437	–	–	1.17%	31
2016 Q4	$2.24M	Hold	30,437	–	–	1.05%	36
2016 Q3	$2.44M	Hold	30,437	–	–	1.15%	30
2016 Q2	$2.4M	Hold	30,437	–	–	1.1%	28
2016 Q1	$2.19M	Hold	30,437	–	–	1.02%	31
2015 Q4	$2.56M	Hold	30,437	–	–	1.15%	27
2015 Q3	$2.55M	Sell	30,437 -3,405	-10%	-$287K	1.12%	28
2015 Q2	$2.83M	Buy	33,842 +30,437	+894%	+$2.32M	1.14%	23
2015 Q1	$247K	Hold	3,405	–	–	0.14%	107
2014 Q4	$235K	Hold	3,405	–	–	0.1%	111
2014 Q3	$221K	Sell	3,405 -7,245	-68%	-$459K	0.09%	120
2014 Q2	$662K	Hold	10,650	–	–	0.29%	86
2014 Q1	$627K	Buy	+10,650	New	+$594K	0.29%	85

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Texan Capital Management's LLY Position: Q2 2017 in Review

Texan Capital Management sold out of Eli Lilly (LLY) in Q2 2017, closing a stake of 30,437 shares — an estimated $2.56M sold.

Texan Capital Management first reported a position in LLY in Q1 2014 and held it in 13 quarters. The position peaked at $2.83M in Q2 2015. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

Texan Capital Management reported no remaining Eli Lilly position as of Q2 2017 after selling out during the quarter.
Texan Capital Management sold 30,437 Eli Lilly shares in Q2 2017, an estimated $2.56M.
Texan Capital Management first reported a position in Eli Lilly in Q1 2014 and held it in 13 quarters.
Texan Capital Management's Eli Lilly position peaked at $2.83M in Q2 2015.
1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Texan Capital Management's 13F filing for Q2 2017, filed 13 Jul 2017.